Vascular dementia clinical trials and research options
A patient-friendly guide for families who want to understand current research in vascular dementia, vascular cognitive impairment, and post-stroke cognitive decline. This is research awareness only — not trial eligibility, medical advice, or treatment guidance.
How VascuMind helps families approach research
STEP 1 — UNDERSTAND
Learn the vascular cognitive pattern
Understand how stroke, small vessel disease, blood pressure, diabetes, PAD, heart disease, and other vascular factors can be relevant to memory and thinking changes.
STEP 2 — BENCHMARK
Create a memory baseline
Use screening and tracking information to support clinician discussion before exploring research pathways.
STEP 3 — ASK
Explore whether research may be relevant
With consent, VascuMind can help route research-interest follow-up. Study teams and clinicians determine eligibility and medical appropriateness.
Over the past 30 years, researchers around the world have conducted hundreds of clinical studies focused on vascular cognitive impairment and related syndromes. These studies have helped researchers understand risk-factor management, post-stroke cognitive change, small vessel disease, inflammation, imaging markers, and investigational approaches.
Research Snapshot (ClinicalTrials.gov)
450+
Total Studies
94
Currently Recruiting
197
Completed Studies
27
Phase 3 or 4 Trials
What researchers are studying now
•Blood pressure and vascular risk-factor interventions — Still a major area of research and clinical discussion.
•Anti-inflammatory, neuroprotective, and regenerative approaches — Investigational therapies must be evaluated through appropriate study teams and regulatory pathways.
•Exercise, rehabilitation, and cognitive training combinations
•Advanced imaging and small vessel disease markers
•Multi-domain risk-reduction studies building on models such as FINGER
What this means for you
Research supports discussing modifiable vascular risk factors with a qualified healthcare professional. The strongest practical next step for most families is to organize the clinical conversation around:
Blood pressure and other vascular risk factors
Stroke/TIA history and secondary prevention questions
Diabetes, cholesterol, smoking, sleep, mood, and medication review
Physical activity, rehabilitation, nutrition, and cognitive tracking
Whether research options are appropriate to ask about
Current studies can be searched at ClinicalTrials.gov. Always discuss clinical trial participation with your physician and the study team.
ClinicalTrials.gov snapshot noted as of June 2026; counts change over time. VascuMind does not determine trial eligibility.
MCI Screen Disclaimer
The MCI Screen referenced by VascuMind is a cognitive screening, benchmarking, and tracking tool sourced from MCI Screen / EMBIC materials. It does not diagnose vascular dementia or any other medical condition and is not a substitute for clinical evaluation. Results should be discussed with a qualified healthcare provider.
These products are dietary supplements and are not intended to diagnose, treat, cure, or prevent vascular dementia, Alzheimer’s disease, MCI, stroke, or any other disease. Always consult your healthcare professional before use.
VascuMind® content is for educational purposes only and does not constitute medical advice or clinical guidance. Sudden neurologic symptoms require immediate emergency care (call 911). Supplement pages use structure/function wellness language, affiliate disclosure, and the required FDA dietary-supplement notice. Full compliance page: /compliance.